Cyprotex’s vision is to enable and enhance the prediction of human exposure, clinical efficacy and toxicological outcome of a drug or chemical. By combining quality data from robust in vitro methods with contemporary in silico technology, we add value, context and relevance to the ADME-Tox data supplied to our customers in the pharmaceutical or chemical industries.
To exceed our customers' expectations in the provision of our services
To maintain our position as the leading ADME-Tox outsourced service provider to the pharmaceutical and chemical industries
To focus on our core deliverables of high quality data at the most cost-effective price to our customers
To expand our customer base and deepen the relationships with our existing clients
To invest in R&D to introduce and further develop unique, cutting edge solutions and services
To share our knowledge and expertise within the industry
To improve the recognition of the Cyprotex brand worldwide